You are here

Our science / Clinical Trials / Find a Trial / NCT00856687

A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Back to Search Print Save as PDF Bookmark Trial

NCT00856687

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Harrow, Middlesex, HA1 3UJ United Kingdom
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Asthma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-60 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males and females 18-60 years.

- Mild asthma

- Atopic to allergens

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Unstable asthma.

- Smokers or recent ex-smokers

- Recent allergen challenge

NCT00856687
Pfizer
Completed
A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Asthma
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
NCT00150397
All Genders
18+
Years
Multiple Sites
Asthma
An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
NCT02219048
All Genders
18+
Years
Multiple Sites
Asthma
PF-04191834 Single Dose Bronchodilatory Study In Asthma.
NCT00723021
All Genders
18+
Years
Multiple Sites
Asthma
A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients
NCT00971893
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now